Chagasic patients lack CD28 expression on many of their circulating T lymphocytes

Scandinavian Journal of Immunology

Volumn 43, Issue 1, 1996, Pages 88-93

  Dutra, W O ^a,b   Martins Filho, O A ^a,b   Cancado J R ^b   Pinto Dias, J C ^a   Brener, Z ^a   Gazzinelli, G ^a   Carvalho, J F ^a   Colley, D G ^c,d,e  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^d U S PUBLIC HEALTH SERVICE   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; APOPTOSIS; ARTICLE; BRAZIL; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

EID: 0030026329     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-9.x     Document Type: Article

References (43)

1. Botazzo GF, Dean BM, McNally JM, Mackay EH, Swift PG, Gamble DR. In situ characterization of autoimmune phenomena and expression of HLA-DR molecules in the pancreas in diabetic insulitis. New Engl J Med 1985;313:353-8.
2. Dutra WO, Martins-Filho OA, Cançado JR, et al. Activated T and B lymphocytes in peripheral blood of patients with Chagas' disease. Int Immunol 1994;6:499-506.
3. + B cells in juvenile reumathoid arthritis. Relationship to IgM rheumatoid factor expression and disease activity. Arthritis Rheum 1992;35:204-11.
4. + lymphocytes. Am J Trop Med Hyg 1993;43:637-43.
5. + B cells in autoimmune disease and lymphoid malignancy. Clin Immunol Immunopathol 1991;59:173-80.
6. Dias JC. The indeterminate form of human chronic Chagas' disease. A clinical epidemiological review. Rev Soc Min Med Trop 1989;22:147-56.
7. Cutait DE, Cutait R. Surgery of chagasic megacolon. World J Surg 1991;15:188-97.
8. Marin-Neto JA, Marzullo P, Marcassa C, Gallo Jr L, Maciel B.C. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thallium-201 scintigraphy. Am J Cardiol 1992;69:780-84.
9. Brener Z. Pathogenesis and immunopathology of chronic Chagas' disease. Mem Inst Osw Cruz 1987;82:205-21.
10. Morato MJF, Brener Z, Cançado JR, Nunes RMB, Chiari E, Gazzinelli G. Cellular immune responses of chagasic patients to antigens derived from different strains and clones. Am J Trop Med Hyg 1986;35:505-12.
11. Higushi ML, De Brito T, Reis MM, et al. Correlation between T. cruzi parasitism and miocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Pathol 1993;2:313-20.
12. Reis DD, Gazzinelli R, Gazzinelli G, Colley DG. Antibodies to T. cruzi express idiotypic patterns that can differentiate between patients with asymptomatic and severe forms of Chagas' disease. J Immunol 1993;150:1611-18.
13. de Tito EH, Braun M, Lazzari JO, Segura EL. Cell mediated reacitivity against human and Trypanosama cruzi antigens according to clinical status in Chagas' disease patients. Immunol Lett 1985;9:249-56.
14. Gazzinelli RT, Gazzinelli G, Cançado JR, Cardoso JE, Brener Z, Colley DG. Two models of idiotypic stimulation of T lymphocytes from patients with Chagas' disease: correlations with clinical forms of infection. Res Immunol 1990;140:757-63.
15. Hansen JA, Martin PJ, Nowinsky RC. Monoclonal antibodies identifying a novel T cell antigen and Ia antigens of human lymphocytes. Immunogenitics 1980;10:247-56.
16. Hara T, Fu SM, Hansen JA. Human T cell activation. II. A new activation pathway used by a major T cell population via a dissulphide-bonded dimer of a 44-kilodalton polypeptide (9.3 antigen). J Exp Med 1985;161:1513-21.
17. Damle NK, Doyle LV, Grosmaire LS, Ledbetter JA. Differential regulatory signals delivered by antibody binding to the CD28 (Tp44) molecule during the activation of human T lymphocytes. J Immunol 1988;140:1753-63.
18. Azuma M, Phillips JH, Lanier LL. CD28 co-stimulation of T cell mediated cytotoxicity. Int J Cancer 1992;7:33-9.
19. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and IL-2 mRNA accumulation. J Exp Med 1991;173:721-30.
20. + T cell subsets. J Exp Med 1988;168:1659-70.
21. Lum LG, Orcutt-Thordarson N, Seigneuret MC, Hansen JA. In vitro regulation of immunoglobulin synthesis by T cell sub-populations defined by a new human T cell antigen (9.3). Cell Immunol 1982;72:122-32.
22. + T cells from HIV-infected persons. J Immunol 1994;153:412-20.
23. - lymphocytes. Antigenic and functional properties. J Immunol 1993;150:1147-59.
24. + lymphocytes during HIV infection. Scand J Immunol 1994;40:485-90.
25. +CD28 cell population in the blood and lung of HIV-positive patients. J Acq Imm Def Syndrome 1993;6:1194-204.
26. Brinchmann JE, Dobloug JH, Heger BH, Haaheim LL, Sannes M, Egeland T. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: Functional and clinical correlations. J Inf Dis 1994;169:730-38.
27. Lanier LL, Phillips JH. Triggering Structures on NK Cells. Cytotoxic Cells. MU Sitkovsky, PA Henkart, eds. Birkhauser Inc, Boston, 1993:pp84.
28. Perusia B, Fanning V, Trinchieri G. A human NK and K cell subset shares with cytotoxic T cells expression of the antigen recognized by antibody OKT8. J Immunol 1983;131:223-31.
29. Jenkins MK. The ups and downs of T cell co-stimulation. Immunity 1994;1:443-8.
30. Azuma M, Ito D, Yagita H et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-85.
31. Freedman AS, Freeman G, Horowitz JC, Daley J, Nadler LM. B7, a B cell-restricted antigen that identifies preactivated B cells. J Immunol 1987;139:3260-71.
32. Freeman GJ, Gribben JG, Vassiliki AB et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human cell proliferation. Science 1993;262:909-12.
33. Yokoshi T, Holly RD, Clark EA. B lymphoblast antigens (BBI) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines and Burkitt's lymphomas. J Immunol 1982;128:823-31.
34. Gimmi CD, Freeman GJ, Gribben K et al. B cell surface B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. Proc Natl Acad Sci USA 1991;88:6575-9.
35. + T cells. J Exp Med 1991;173:759-70.
36. Linsley PS, Clark EA, Ledbetter JA. T cell antigen CD28 mediates adhesion with B cells by interacting with activation antigen B7/BB-1. Proc Natl Acad Sci USA 1990;87:5031-4.
37. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T cell activation. Immunol Today 1990;13:211-5.
38. Schwartz R. Immunological tolerance. In: Paul, W.E. ed. Fundamental Immunology. New York: Raven Press, 1993;677-731.
39. + T cell death by apoptosis in experimental Chagas' disease. J Immunol 1995;154:744-52.
40. Azuma M, Cayabyab M, Buck D, Philips JH, Lanier LL. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer cell leukaemia cell line. J Immunol 1992;149:1115-24.
41. Azuma M, Cayabyab M, Philips JH, Lanier LL. Requirements for CD28 dependent T cell mediated cytotoxicity. J Immunol 1993;150:2091-112.
42. Testi R, Lanier LL. Functional expression of CD28 on T cell antigen receptor gamma-delta-bearing T lymphocytes. Eur J Immunol 1989;19:185-95.
43. + cells with a limited alloreactive T cell receptor repertoire. J Immunol 1989;143:2783-92.